To improve lives around the world, biomedical innovation must emerge from the lab and be placed in the hands of medical professionals treating patients.
As the journey from the lab to the bedside continues to shift, and as medical and pharmaceutical giants look to expand their development partnerships, leading academic medical centers are bolstering their research initiatives and seizing the opportunity to assume a crucial role in improving healthcare.
Baylor College of Medicine Ventures (BCMV) has successfully positioned itself as a partner-of-choice for industry players looking to navigate this journey, advancing exciting collaborations between Baylor and various commercial partners. BCMV supports, cultivates and accelerates translational research by fostering discovery, retaining promising young faculty and securing strategic support, especially in the form of philanthropy.
Philanthropic support for early-stage concepts empowers visionary donors to partner with the College in evaluating potential candidates for seed funding, providing crucial resourceswhen other entities will not. Philanthropy also opens new opportunities for traditional investment in companies launched through Baylor’s commercialization activities, affording forward-thinking donors the chance to become first-round investors in the production of healthcare and biomedical sciences breakthroughs.
President, CEO and Executive Dean
Baylor College of Medicine
CEO
PHIOGEN INC.
Associate Professor, Department of Pathology & Immunology and the Center for Cell and Gene Therapy
Baylor College of Medicine
Chief Scientific Officer
March Biosciences
Joseph Melnick Endowed Chair of Virology and Microbiology
Professor, Department of Molecular Virology and Microbiology
Baylor College of Medicine
Co-Founder
PHIOGEN INC.
Chief Scientific Innovation Officer
Kyle and Josephine Morrow Chair in Molecular Virology and Microbiology
Professor and Chair, Department of Molecular Virology and Microbiology
Director, Alkek Center for Metagenomics and Microbiome Research
Baylor College of Medicine
Executive Director
Therapeutic Innovation Center (THINC)
Robert A. Welch Chair in Chemistry
McNair Scholar in Cancer Research
Professor, Deptartment of Molecular & Human Genetics
Baylor College of Medicine
Co-founder, Marlinspike Therapeutics
Baylor College of Medicine Ventures fosters a culture of commercialization by engaging university innovators, entrepreneurs and industry to fully develop ideas and identify market opportunities or collaborative ventures for the benefit of society.
Our team of commercial experts cultivate ideas, connect people, drive technology management, and elevate business engagement. We also partner with philanthropic advisors to engage support at critical points and increase the chances for breakthroughs by developing and de-risking commercial targets.
